Post by Gubra

Gubra will be attending the upcoming Keystone Symposia on #MASH and #CKD in Vancouver this April. Our team will present two posters showcasing new data and capabilities: Chronic Kidney Disease Research Henrik Björk Hansen will present: Survodutide, a Novel Dual GLP-1 Receptor/Glucagon Receptor Agonist, Improves Kidney Health in a Mouse Model of Advanced Diabetic Kidney Disease - Poster #2520 | Poster Session 2 - April 14, 12:00 PM MASH Capabilities Allison Butt will present: Differential Therapeutic Profile of Efruxifermin in the GAN DIO-MASH and CDAA-HFD Mouse Models of MASH - Poster #1041 | Poster Session 1 - April 13, 7:30 PM If you are attending, feel free to reach out to connect with the team and learn more about our translational preclinical models here: https://lnkd.in/dUsHGtdD #KeystoneSymposia #MASH #CKD #PreclinicalResearch #DrugDevelopment #MetabolicDisease